|
|
|
Insider
Information: |
Gordon Carl L |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
11,800 |
|
Indirect Shares
|
43,664,116 |
|
|
Direct
Value |
$17,346 |
|
|
Indirect Value
|
$689,636,965 |
|
|
Total
Shares |
43,675,916 |
|
|
Total
Value |
$689,654,311 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-1.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Acadia Pharmaceuticals Inc |
ACAD |
Director |
2004-06-02 |
0 |
2005-04-20 |
1,395,612 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2005-12-02 |
0 |
2005-12-02 |
1,100,000 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
|
0 |
2011-02-08 |
2,828,941 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Amarin Corp Plc |
AMRN |
Director |
2011-02-28 |
0 |
2012-09-04 |
5,700 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Acceleron Pharma Inc |
XLRN |
Director |
|
0 |
2013-09-18 |
8,006 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Intellia Therapeutics, Inc. |
NTLA |
Director |
2016-05-11 |
0 |
2016-05-11 |
2,662,180 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Selecta Biosciences Inc |
SELB |
Director, 10% Owner |
|
0 |
2016-06-27 |
1,825,415 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
X4 Pharmaceuticals Inc |
XFOR |
Director, 10% Owner |
2017-11-20 |
0 |
2017-11-20 |
1,868,966 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Armo Biosciences Inc |
ARMO |
Director |
2018-01-30 |
0 |
2018-06-22 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Alector, Inc. |
ALEC |
Director, 10% Owner |
2019-02-11 |
0 |
2019-02-11 |
203,200 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Prevail Therapeutics Inc. |
PRVL |
Director, 10% Owner |
|
0 |
2021-01-22 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Keros Therapeutics, Inc. |
KROS |
Director |
2020-04-13 |
0 |
2020-04-13 |
1,119,812 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2020-04-24 |
0 |
2021-03-30 |
2,212,571 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Adicet Bio, Inc |
ACET |
|
2024-06-05 |
11,800 |
2024-06-05 |
11,447,140 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Kinnate Biopharma Inc. |
KNTE |
Director, 10% Owner |
2020-12-07 |
0 |
2024-04-03 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Terns Pharmaceuticals, Inc. |
TERN |
Director, 10% Owner |
2021-02-09 |
0 |
2022-12-23 |
7,619,135 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
|
0 |
2021-02-05 |
5,826,224 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Theseus Pharmaceuticals, Inc. |
THRX |
Director, 10% Owner |
2021-10-12 |
0 |
2024-02-14 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Arrivent Biopharma, Inc. |
AVBP |
Director, 10% Owner |
2024-01-30 |
0 |
2024-01-30 |
1,513,664 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
101 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|